[ {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAkG5c7KQkNNiInVrk1O_HJn-W7QZ8abdWUwsZyuJrij8",
    "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ],
    "http://www.nanopub.org/nschema#hasAssertion" : [ {
      "@id" : "http://purl.org/np/RAkG5c7KQkNNiInVrk1O_HJn-W7QZ8abdWUwsZyuJrij8#assertion"
    } ],
    "http://www.nanopub.org/nschema#hasProvenance" : [ {
      "@id" : "http://purl.org/np/RAkG5c7KQkNNiInVrk1O_HJn-W7QZ8abdWUwsZyuJrij8#provenance"
    } ],
    "http://www.nanopub.org/nschema#hasPublicationInfo" : [ {
      "@id" : "http://purl.org/np/RAkG5c7KQkNNiInVrk1O_HJn-W7QZ8abdWUwsZyuJrij8#pubinfo"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAkG5c7KQkNNiInVrk1O_HJn-W7QZ8abdWUwsZyuJrij8#Head"
}, {
  "@graph" : [ {
    "@id" : "http://purl.obolibrary.org/obo/DOID_9538",
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Disease"
    } ]
  }, {
    "@id" : "http://purl.org/np/RAkG5c7KQkNNiInVrk1O_HJn-W7QZ8abdWUwsZyuJrij8#association",
    "@type" : [ "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement" ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ {
      "@id" : "http://purl.obolibrary.org/obo/DOID_9538"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ {
      "@id" : "https://w3id.org/biolink/vocab/treats"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ {
      "@id" : "https://identifiers.org/drugbank:DB08910"
    } ],
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "pomalyst is a thalidomide analogue indicated in combination with dexamethasone for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 6 days of completion of the last therapy 1 1 pomalyst in combination with dexamethasone is indicated for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 6 days of completion of the last therapy"
    } ],
    "https://w3id.org/biolink/vocab/association_type" : [ {
      "@id" : "https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation"
    } ],
    "https://w3id.org/biolink/vocab/provided_by" : [ {
      "@id" : "https://w3id.org/um/NeuroDKG"
    } ],
    "https://w3id.org/biolink/vocab/relation" : [ {
      "@id" : "https://schema.org/TreatmentIndication"
    } ]
  }, {
    "@id" : "https://identifiers.org/drugbank:DB08910",
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Drug"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAkG5c7KQkNNiInVrk1O_HJn-W7QZ8abdWUwsZyuJrij8#assertion"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAkG5c7KQkNNiInVrk1O_HJn-W7QZ8abdWUwsZyuJrij8#assertion",
    "http://www.w3.org/ns/prov#wasAttributedTo" : [ {
      "@id" : "https://orcid.org/0000-0002-1468-3557"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAkG5c7KQkNNiInVrk1O_HJn-W7QZ8abdWUwsZyuJrij8#provenance"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAkG5c7KQkNNiInVrk1O_HJn-W7QZ8abdWUwsZyuJrij8",
    "http://purl.org/dc/terms/created" : [ {
      "@type" : "http://www.w3.org/2001/XMLSchema#dateTime",
      "@value" : "2021-06-12T14:48:20.601+02:00"
    } ],
    "http://purl.org/dc/terms/creator" : [ {
      "@id" : "https://orcid.org/0000-0002-1468-3557"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate" : [ {
      "@id" : "http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate" : [ {
      "@id" : "http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate" : [ {
      "@id" : "http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs"
    } ]
  }, {
    "@id" : "http://purl.org/np/RAkG5c7KQkNNiInVrk1O_HJn-W7QZ8abdWUwsZyuJrij8#sig",
    "http://purl.org/nanopub/x/hasAlgorithm" : [ {
      "@value" : "RSA"
    } ],
    "http://purl.org/nanopub/x/hasPublicKey" : [ {
      "@value" : "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB"
    } ],
    "http://purl.org/nanopub/x/hasSignature" : [ {
      "@value" : "eexbn+e6FdL1dTmywQbI2yGrIwH4DENS8j594/Rnj4wpiyXTe/5/DiZgSgbqUvG9ae0AUG+wyAXgCC/sdzuxGrDTFJa8ZlRVgjOKB5dGTE9P/TJYiMEyWZ3dlAxxlCX0hurwxRu/l+yfzWxikNx/Mp6Eq7/nxfHUgR6b9UHf/JM="
    } ],
    "http://purl.org/nanopub/x/hasSignatureTarget" : [ {
      "@id" : "http://purl.org/np/RAkG5c7KQkNNiInVrk1O_HJn-W7QZ8abdWUwsZyuJrij8"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAkG5c7KQkNNiInVrk1O_HJn-W7QZ8abdWUwsZyuJrij8#pubinfo"
} ]